Hypermarcas Share Holder Equity 2012-2025 | HYPMY

Hypermarcas share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Hypermarcas Annual Share Holder Equity
(Millions of US $)
2024 $2,244
2023 $2,307
2022 $2,064
2021 $1,822
2020 $1,793
2019 $2,207
2018 $2,262
2017 $2,423
2016 $2,526
2015 $2,452
2014 $3,194
2013 $3,299
2012 $3,536
2011 $3,994
Hypermarcas Quarterly Share Holder Equity
(Millions of US $)
2025-09-30 $2,250
2025-06-30 $2,117
2025-03-31 $2,004
2024-12-31 $2,244
2024-09-30 $2,203
2024-06-30 $2,304
2024-03-31 $2,367
2023-12-31 $2,307
2023-09-30 $2,335
2023-06-30 $2,234
2023-03-31 $2,082
2022-12-31 $2,064
2022-09-30 $2,003
2022-06-30 $2,076
2022-03-31 $1,895
2021-12-31 $1,822
2021-09-30 $1,854
2021-06-30 $1,811
2021-03-31 $1,711
2020-12-31 $1,793
2020-09-30 $1,730
2020-06-30 $1,689
2020-03-31 $1,985
2019-12-31 $2,207
2019-09-30 $2,181
2019-06-30 $2,184
2019-03-31 $2,237
2018-12-31 $2,262
2018-09-30 $2,076
2018-06-30 $2,244
2018-03-31 $2,439
2017-12-31 $2,423
2017-09-30 $2,542
2017-06-30 $2,447
2017-03-31 $2,712
2016-12-31 $2,526
2016-09-30 $2,787
2016-06-30 $2,590
2016-03-31 $2,323
2015-12-31 $2,452
2015-09-30 $2,209
2015-06-30 $2,710
2015-03-31 $2,460
2014-12-31 $3,194
2014-09-30 $3,271
2014-06-30 $3,274
2014-03-31 $3,034
2013-12-31 $3,299
2013-09-30 $3,074
2013-06-30 $3,368
2013-03-31 $3,496
2012-12-31 $3,536
2012-09-30 $3,330
2012-06-30 $3,421
2012-03-31 $3,791
2011-12-31 $3,994
2011-09-30 $4,070
2011-06-30 $4,254
2011-03-31 $4,049
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.906B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.784B 32.96
Zoetis (ZTS) United States $55.122B 19.73
Takeda Pharmaceutical (TAK) Japan $51.166B 10.44
Daiichi Sankyo, - (DSNKY) Japan $38.417B 19.13
BeOne Medicines - (ONC) Switzerland $37.465B 198.63
Sandoz Group AG (SDZNY) Switzerland $34.412B 0.00
United Therapeutics (UTHR) United States $20.227B 17.80
Merck (MKKGY) Germany $18.999B 11.71
Shionogi (SGIOY) Japan $15.585B 14.31
Neurocrine Biosciences (NBIX) United States $13.501B 32.40
IPSEN (IPSEY) France $13.099B 0.00
Summit Therapeutics (SMMT) United States $12.994B 0.00
Ionis Pharmaceuticals (IONS) United States $12.867B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.287B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.190B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.967B 21.19
Grifols, S.A (GRFS) Spain $6.202B 0.00
Stevanato Group S.p.A (STVN) Italy $5.887B 32.95
Crinetics Pharmaceuticals (CRNX) United States $5.258B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.547B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.310B 20.46
Indivior (INDV) United States $4.123B 16.83
NewAmsterdam Pharma (NAMS) Netherlands $3.848B 0.00
Corcept Therapeutics (CORT) United States $3.819B 41.26
Centessa Pharmaceuticals (CNTA) United Kingdom $3.123B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.966B 9.46
Dyne Therapeutics (DYN) United States $2.499B 0.00
Ocular Therapeutix (OCUL) United States $2.433B 0.00
Soleno Therapeutics (SLNO) United States $2.340B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.101B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.949B 23.09
Ardelyx (ARDX) United States $1.941B 0.00
Guardian Pharmacy Services (GRDN) United States $1.858B 35.79
Amylyx Pharmaceuticals (AMLX) United States $1.858B 0.00
Harrow (HROW) United States $1.745B 107.09
Oruka Therapeutics (ORKA) United States $1.668B 0.00
Enliven Therapeutics (ELVN) United States $1.615B 0.00
Collegium Pharmaceutical (COLL) United States $1.486B 7.36
BioCryst Pharmaceuticals (BCRX) United States $1.416B 84.00
Relay Therapeutics (RLAY) United States $1.307B 0.00
Xeris Biopharma Holdings (XERS) United States $1.264B 0.00
Savara (SVRA) United States $1.259B 0.00
Evotec AG (EVO) Germany $1.243B 0.00
Aktis Oncology (AKTS) United States $1.033B 0.00
Theravance Biopharma (TBPH) United States $1.032B 43.34
ARS Pharmaceuticals (SPRY) United States $1.032B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Xencor (XNCR) United States $0.928B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.864B 20.42
KalVista Pharmaceuticals (KALV) United States $0.804B 0.00
Nektar Therapeutics (NKTR) United States $0.751B 0.00
Esperion Therapeutics (ESPR) United States $0.712B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.683B 6.10
Bioventus (BVS) United States $0.662B 13.56
ProKidney (PROK) United States $0.647B 0.00
Lexeo Therapeutics (LXEO) United States $0.528B 0.00
Lyell Immunopharma (LYEL) United States $0.512B 0.00
Zevra Therapeutics (ZVRA) United States $0.508B 0.00
Elite Pharmaceuticals (ELTP) United States $0.506B 0.00
Organogenesis (ORGO) United States $0.487B 0.00
Altimmune (ALT) United States $0.482B 0.00
Aclaris Therapeutics (ACRS) United States $0.479B 0.00
Siga Technologies (SIGA) United States $0.477B 6.53
4D Molecular Therapeutics (FDMT) United States $0.439B 0.00
Nature's Sunshine Products (NATR) United States $0.424B 25.24
Aquestive Therapeutics (AQST) United States $0.410B 0.00
USANA Health Sciences (USNA) United States $0.407B 11.35
Cybin (HELP) Canada $0.377B 0.00
Akebia Therapeutics (AKBA) United States $0.364B 0.00
Aldeyra Therapeutics (ALDX) United States $0.300B 0.00
Protara Therapeutics (TARA) United States $0.298B 0.00
Avalo Therapeutics (AVTX) United States $0.292B 0.00
Profound Medical (PROF) Canada $0.290B 0.00
OmniAb (OABI) United States $0.289B 0.00
Achieve Life Sciences (ACHV) Canada $0.289B 0.00
Relmada Therapeutics (RLMD) United States $0.279B 0.00
Larimar Therapeutics (LRMR) United States $0.275B 0.00
Silence Therapeutics (SLN) United Kingdom $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.268B 0.00
Fractyl Health (GUTS) United States $0.254B 0.00
Journey Medical (DERM) United States $0.241B 0.00
Enlivex Therapeutics (ENLV) Israel $0.233B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.221B 0.00
MediWound (MDWD) Israel $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
AleAnna (ANNA) United States $0.189B 0.00
Minerva Neurosciences (NERV) United States $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.178B 0.00
Surrozen (SRZN) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.152B 0.00
Context Therapeutics (CNTX) United States $0.151B 0.00
Unicycive Therapeutics (UNCY) United States $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.124B 0.00
Incannex Healthcare (IXHL) Australia $0.123B 0.00
Avita Medical (RCEL) United States $0.119B 0.00
Karyopharm Therapeutics (KPTI) United States $0.116B 0.00
Prelude Therapeutics (PRLD) United States $0.114B 0.00
Vivani Medical (VANI) United States $0.110B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Pyxis Oncology (PYXS) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Champions Oncology (CSBR) United States $0.098B 41.71
Korro Bio (KRRO) United States $0.089B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
PolyPid (PYPD) Israel $0.073B 0.00
NRx Pharmaceuticals (NRXP) United States $0.067B 0.00
Acrivon Therapeutics (ACRV) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 54.75
Rafael Holdings (RFL) United States $0.062B 0.00
Metagenomi Therapeutics (MGX) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.061B 0.00
Arch Biopartners (ACHFF) Canada $0.060B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Nutriband (NTRB) United States $0.054B 0.00
Lipocine (LPCN) United States $0.054B 0.00
Lite Strategy (LITS) United States $0.049B 0.00
Talphera (TLPH) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
Plus Therapeutics (PSTV) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Wellgistics Health (WGRX) United States $0.036B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
TherapeuticsMD (TXMD) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Klotho Neurosciences (KLTO) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
Traws Pharma (TRAW) United States $0.019B 0.02
Liminatus Pharma (LIMN) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Inotiv (NOTV) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00